Procter & GamblePGBUYJan 20, 2014Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
Had a few issues over the last little while. Large companies like this were all highlighted as to their ability to grow in China. China has been a lot more difficult to deal with than people thought. This has hurt the stock a little. All in all, it is a great company with great products and is not trading at a very high multiple. Global growth will help this company. Made a few changes, which will help them. Expecting better top line growth.